FrancophonIA/ELRC3.0 huggingface dataset:
English: The European Commission granted a marketing authorisation valid throughout the European Union for Lamivudine/Zidovudine Teva on 28 February 2011.
Maltese: Il-Kummissjoni Ewropea tat awtorizzazzjoni għat-tqegħid fis-suq għal Lamivudine/Zidovudine Teva valida fl-Unjoni Ewropea kollha fit-28 ta' Frar 2011.
English: Children weighing less than 14 kg will need to use separate oral solutions containing lamivudine and zidovudine.
Maltese: Tfal li jiżnu inqas minn 14-il kg jeħtieġ li jużaw taħlitiet orali separati li fihom il-lamivudina u z-zidovudina.
English: Lamivudine/Zidovudine Teva is used in combination with at least one other HIV medicine to treat patients infected with human immunodeficiency virus (HIV), the virus that causes acquired immune deficiency syndrome (AIDS).
Maltese: Lamivudine/Zidovudine Teva jintuża flimkien ma' mill-inqas mediċina oħra kontra l-HIV biex jikkura pazjenti infettati bil-virus tal-immunodefiċjenza umana (HIV), il-virus li jikkawża s-sindromu millimmonudefiċjenza akkwżita (AIDS).
English: Lamivudine/Zidovudine Teva lamivudine/zidovudine
Maltese: Lamivudina/zidovudina
English: The recommended dose of Lamivudine/Zidovudine Teva for patients over 12 years of age who weigh at least 30 kg is one tablet taken twice a day.
Maltese: Id-doża rakkomandata ta' Lamivudine/Zidovudine Teva għal pazjenti ta' aktar minn 12-il sena li jiżnu mill-inqas 30 kg hija pillola waħda darbtejn kull jum.
English: In children (below 12 years of age) weighing between 14 and 30 kg, the number of tablets and half tablets to take depends on their weight.
Maltese: Fit-tfal (taħt it-12-il sena) li jiżnu bejn 14 u 30 kg, l-għadd ta' pilloli u nofs pilloli li jittieħdu jiddependi mill-piż tagħhom.
English: Lamivudine/Zidovudine Teva, taken in combination with at least one other HIV medicine, reduces the amount of HIV in the blood and keeps it at a low level.
Maltese: Lamivudine/Zidovudine Teva, meħud flimkien ma' mill-inqas mediċina waħda oħra kontra l-HIV, inaqqas l-ammont ta' HIV fid-demm u jżommu f'livell baxx.
English: This means that Lamivudine/Zidovudine Teva is similar to a ‘reference medicine' already authorised in the European Union (EU) called Combivir.
Maltese: Dan ifisser li Lamivudine/Zidovudine Teva huwa simili għal ‘mediċina ta' referenza' diġà awtorizzata fl-Unjoni Ewropea (UE) bl-isem Combivir.
English: What is Lamivudine/Zidovudine Teva?
Maltese: Lamivudine/Zidovudine Teva
English: Other information about Lamivudine/Zidovudine Teva
Maltese: Informazzjoni oħra dwar Lamivudine/Zidovudine Teva
English: Because Lamivudine/Zidovudine Teva is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Combivir.
Maltese: Peress li Lamivudine/Zidovudine Teva huwa mediċina ġenerika, l-istudji fuq il-pazjenti ġew limitati għal testitjiet li jiddeterminaw jekk hijiex bijoekwivalenti għall-mediċina ta' referenza Combivir.
English: Because Lamivudine/Zidovudine Teva is a generic medicine, its benefits and risks are taken as being the same as the reference medicine's.
Maltese: Peress li Lamivudine/Zidovudine Teva huwa mediċina ġenerika, il-benefiċċji u r-riskji tiegħu huma meqjusa l-istess bħal dawk tal-mediċina ta' referenza.
English: Lamivudine/Zidovudine Teva does not cure HIV infection or AIDS, but it may delay the damage to the immune system and the development of infections and diseases associated with AIDS.
Maltese: Lamivudine/Zidovudine Teva ma jfejjaqx infezzjoni mill-HIV jew l-AIDS, iżda jista' jittardja l-ħsara lis-sistema immunitarja u l-iżvilupp ta' infezzjonijiet u mard assoċjati mal-AIDS.
English: How has Lamivudine Zidovudine Teva been studied?
Maltese: Kif ġie studjat Lamivudine Zidovudine Teva?
English: What are the benefits and risks of Lamivudine/Zidovudine Teva?
Maltese: X'inhuma l-benefiċċji u r-riskji ta' Lamivudine/Zidovudine Teva?
English: Both active substances have been available in the EU for a number of years: lamivudine has been authorised as Epivir since 1996 and zidovudine has been available in the EU since the mid-1980s.
Maltese: Iż-żewġ sustanzi attivi ilhom disponibbli fl-UE għal numru ta' snin: il-lamivudina ilha awtorizzata bħala Epivir sa mill-1996 u z-zidovudina ilha awtorizzata fl-UE min-nofs it-tmeninijiet.
English: Ref.: EMEA/484536/2009 EMEA/H/C/1018
Maltese: EMEA/484536/2009 EMEA/H/C/1018
English: It is available as white capsules (200 mg).
Maltese: Huwa disponibbli bħala kapsuli bojod (200 mg).
English: The European Commission granted a marketing authorisation valid throughout the EU for Ribavirin Teva to Teva Pharma B.V. on 31 March 2009.
Maltese: Il-Kummissjoni Ewropea tat awtorizzazzjoni għat-tqegħid fis-suq valida fl-Unjoni Ewropea kollha għal Ribavirin Teva lil Teva Pharma B.V. fil-31 ta' Marzu 2009.
English: The active substance in Ribavirin Teva, ribavirin, is an antiviral belonging to the class ‘nucleoside analogues'.
Maltese: Is-sustanza attiva f'Ribavirin Teva, ribavirin, hija antivirali li tappartjeni għall-klassi ‘nucleoside analogues'.
English: Ribavirin Teva is a ‘generic medicine'.
Maltese: Ribavirin Teva huwa ‘mediċina ġenerika'.
English: It should only be taken by patients weighing at least 47 kg.
Maltese: Jista' jittieħed biss minn pazjenti li jkunu jiżnu 'l fuq minn 47 kg.
English: Ribavirin Teva is a medicine that contains the active substance ribavirin.
Maltese: Ribavirin Teva huwa mediċina li fiha s-sustanza attiva ribavirin.
English: Ribavirin Teva must never be used on its own but only together with interferon alfa-2b (another medicine used in hepatitis).
Maltese: Ribavirin Teva ma għandu qatt jintuża waħdu iżda flimkien ma' interferon alfa-2b (mediċina oħra użata fl-epatite).
English: If you want more information on the basis of the CHMP recommendations, read the Scientific Discussion (also part of the EPAR).
Maltese: Jekk tixtieq aktar informazzjoni relatata mar-rakkomandazzjonijiet tas-CHMP, aqra d-Diskussjoni Xjentifika (parti wkoll mill-EPAR).
English: For more information on generic medicines, see the question-and-answer document here.
Maltese: Għall-aktar informazzjoni dwar ilmediċini ġeneriċi, ara id-dokument mistoqsija-u-tweġiba hawn.
English: Ribavirin Teva is used to treat patients aged three years and older who have chronic (long-term) hepatitis C (a disease of the liver due to an infection with the hepatitis C virus).
Maltese: Ribavirin Teva jintuża biex jittratta pazjenti minn 3 snin 'il fuq li jbatu minn epatite Ċ kronika (fuq tul ta' żmien) (marda tal-fwied ikkaġunata mill-virus tal-epatite Ċ).
English: Because Ribavirin Teva is a generic medicine, studies have been limited to tests to demonstrate that it is bioequivalent to the reference medicine.
Maltese: Billi Ribavirin Teva huwa mediċina ġenerika, l-istudji ġew limitati għal testitjiet biex jiddeterminaw il-bijoekwivalenza tiegħu mal-mediċina ta' referenza.
English: Because Ribavirin Teva is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as those of the reference medicine.
Maltese: Minħabba li Ribavirin Teva huwa mediċina ġenerika u huwa bijoekwivalenti għall-mediċini ta' referenza, il-benefiċċju u r-riskju tiegħu huma meqjusa li huma l-istess bħal dawk tal-mediċina ta' referenza.
English: Why has Ribavirin Teva been approved?
Maltese: Għaliex ġie approvat Ribavirin Teva?
English: What is Ribavirin Teva?
Maltese: Kif tintuża Ribavirin Teva?
English: Therefore, the CHMP's view was that, as for Rebetol, the benefit outweighs the identified risk.
Maltese: Għaldaqstant, il-fehma tas-CHMP kienet li, bħal f'Rebetol, il-benefiċċji jegħlbu r-riskji identifikati.
English: The Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Ribavirin Teva has been shown to have comparable quality and to be bioequivalent to Rebetol.
Maltese: Il-Kumitat għall-Prodotti Mediċinali għall-Użu mill-Bniedem (CHMP) ikkonkluda li, b'mod konformi mal-ħtiġijiet tal-UE, Ribavirin Teva wera li għandu kwalità komparabbli ma' u huwa bijoekwivlenti għal Rebetol.
English: How has Ribavirin Teva been studied?
Maltese: Kif ġie studjat Ribavirin Teva?
English: ATCvet code: QP54AA05.
Maltese: QP54AA05
English: Pharmacotherapeutic group: antiparasitic products, insecticides and repellents, macrocyclic lactones.
Maltese: Grupp farmako-terapewtiku: prodotti kontra l-parassiti, insettiċidi u repellenti, macrocyclic lactones.
English: Butylated hydroxytoluene (E321) 0.08%.
Maltese: Ingredjenti Oħra: Butylated hydroxytoluene (E321) 0.08%
English: 3 pipettes 6 pipettes
Maltese: 3 pipetti 6-il pipetta.
English: 3 pipettes, 15 pipettes
Maltese: 3 pipetti 15-il pipetta.
English: nominal pipette size, ml
Maltese: daqs nominali tal-pipetta, ml
English: • Treatment of biting lice infestations (Felicola subrostratus)
Maltese: • Kura għal infestazzjonijiet ta' qamel li jigdem (Felicola subrostratus)
English: Potency (mg/ml)
Maltese: Qawwa (mg/ml)
English: Selamectin is a semi-synthetic compound of the avermectin class.
Maltese: Selamektin hija sustanza semi-sintetika tal-klassi tal-avermektin.
English: The veterinary medicinal product is presented in a white plastic pipette formed from a layer of polypropylene/cyclic olefin copolymer/polypropylene with a layer of polyethylene/ethylene vinyl alcohol/polyethylene.
Maltese: Il-prodott mediċinali veterinarju huwa ppreżentat f'pipetta bajda tal-plastik iffurmata minn saff ta' polipropilene / ċikliku olefin kopolimer / polipropilene b'saff ta' polyethylene / ethylene vinyl alcohol / polyethylene.
English: • Treatment of ear mites (Otodectes cynotis).
Maltese: • Kura għad-dud tal-widnejn (Otodectes cynotis).
English: Date of first authorisation: 17/04/2019
Maltese: DATA TAL-EWWEL AWTORIZZAZZJONI / TIĠDID TAL-AWTORIZZAZZJONI Data tal-ewwel awtorizzazzjoni: 17/04/2019
English: Chanhold 15 mg Chanhold 30 mg Chanhold 45 mg Chanhold 60 mg Chanhold 60 mg Chanhold 120 mg Chanhold 240 mg Chanhold 360 mg selamectin
Maltese: Chanhold 15 mg Chanhold 30 mg Chanhold 45 mg Chanhold 60 mg Chanhold 60 mg Chanhold 120 mg Chanhold 240 mg Chanhold 360 mg selamektin
English: CARTON, 15 mg
Maltese: KAXXA, 15 mg
English: • Treatment of adult intestinal hookworms (Ancylostoma tubaeforme).
Maltese: • Kura għall-forma adulta tal-hookworm fl-imsaren (Ancylostoma tubaeforme).
English: Selamectin 15 mg
Maltese: Selamektin 15 mg
English: Selamectin 45 mg Selamectin 60 mg
Maltese: Selamektin 45 mg Selamektin 60 mg
English: • Treatment of sarcoptic mange (caused by Sarcoptes scabiei)
Maltese: • Kura għal sarcoptic mange (ikkawżata minn Sarcoptes scabiei).
English: België/Belgique/Belgien Chanelle Pharmaceuticals Manufacturing Ltd. Loughrea
Maltese: België/Belgique/Belgien Chanelle Pharmaceuticals Manufacturing Ltd.
English: 15 mg selamectin 30 mg selamectin 45 mg selamectin 60 mg selamectin 120 mg selamectin 240 mg selamectin 360 mg selamectin
Maltese: 15 mg selamektin 30 mg selamektin 45 mg selamektin 60 mg selamektin 120 mg selamektin 240 mg selamektin 360 mg selamektin
English: Selamectin 30 mg Selamectin 60 mg Selamectin 120 mg Selamectin 240 mg Selamectin 360 mg
Maltese: Selamektin 30 mg Selamektin 60 mg Selamektin 120 mg Selamektin 240 mg Selamektin 360 mg
English: Cats:
Maltese: Teл:
English: CARTON, 30 mg, 60 mg, 120 mg, 240 mg, 360 mg for dogs
Maltese: KAXXA, 30 mg, 60 mg, 120 mg, 240 mg, 360 mg għall-klieb
English: Activity has also been demonstrated against heartworm larvae.
Maltese: Instab ukoll li jkun hemm effett kontra l-larvi tal-heartworm
English: Luxembourg/Luxemburg Chanelle Pharmaceuticals Manufacturing Ltd. Loughrea
Maltese: Luxembourg/Luxemburg Chanelle Pharmaceuticals Manufacturing Ltd.
English: Excipients:
Maltese: Klieb:
English: 2.6-7.5 1 pipette of Chanhold 45 mg for cats 2.6-7.5 kg
Maltese: 2,6 - 7,5 1 pipetta ta' Chanhold 45 mg għal qtates 2.6-7.5 kg
English: This product is not effective against adult D. immitis.
Maltese: Dan il-prodott ma jaħdimx kontra l-forma adulta tad-D. immitis.
English: EU/2/19/236/007 EU/2/19/236/008 EU/2/19/236/009 EU/2/19/236/010 EU/2/19/236/011 EU/2/19/236/012 EU/2/19/236/013 EU/2/19/236/014 EU/2/19/236/015 EU/2/19/236/016
Maltese: EU/2/19/236/011 EU/2/19/236/012 EU/2/19/236/013 EU/2/19/236/014
English: 7.6-10.0 1 pipette of Chanhold 60 mg for cats 7.6-10 kg
Maltese: 7,6 - 10,0 1 pipetta ta' Chanhold 60 mg għal qtates 7.6-10.0 kg
English: The systemic persistence of selamectin in plasma and the lack of extensive metabolism provide effective concentrations of selamectin for the duration of the inter-dosing interval (30 days).
Maltese: Il-persistenza sistemika tas-selamektin fid-demm u n-nuqqas ta' metaboliżmu estensiv iwasslu għal saħħa effettiva biżżejjed fil-perjodu ta' bejn doża u oħra (30 ġurnata).
English: 5.2 Pharmacokinetic particulars
Maltese: .2 Tagħrif farmakokinetiku >
English: Incompatibilities Not applicable.
Maltese: Inkompatibilitajiet:
English: CARTON, 45 mg, 60 mg for cats
Maltese: KAXXA, 45 mg. 60 mg għall-qtates
English: • Prevention of heartworm disease caused by Dirofilaria immitis with monthly administration.
Maltese: • Prevenzjoni mill-marda tal-heartworm ikkawżata mid-Dirofilaria immitis b'amministrazzjoni kull xahar.
English: Chanelle Pharmaceuticals Manufacturing Ltd, Loughrea,
Maltese: Chanelle Pharmaceuticals Manufacturing Ltd., Loughrea, Co.
English: 40.1-60.0 1 pipette of Chanhold 360 mg for dogs 40.1-60.0 kg
Maltese: 1-40.0 kg 40,1 - 60,0 1 pipetta ta' Chanhold 360 mg għal klieb 4.1-60.0 kg
English: Република България Chanelle Pharmaceuticals Manufacturing Ltd. Loughrea
Maltese: Република България Chanelle Pharmaceuticals Manufacturing Ltd.
English: The prolonged persistence and slow elimination of selamectin from plasma is reflected in the terminal elimination half-life values of 8 and 11 days in cats and dogs respectively.
Maltese: Il-persistenza fit-tul tas-selamektin u leliminazzjoni mid-demm bil-mod huma riflessi f'valuri tat-terminal elimination half-life ta' tmint ijiem fil-qtates u ħdax-il jum fil-klieb.
English: ≤ 2.5 1 pipette of Chanhold 15 mg for cats and dogs ≤ 2.5 kg
Maltese: 1 pipetta ta' Chanhold 15 mg għal qtates u klieb ≤ 2.5 kg
English: Chanhold 45 mg spot-on solution for cats 2.6-7.5 kg Chanhold 60 mg spot-on solution for cats 7.6-10.0 kg selamectin
Maltese: Chanhold 45 mg soluzzjoni għal użu topikali għall-qtates 2.6-7.5 kg Chanhold 60 mg soluzzjoni għal użu topikali għall-qtates 7.6-10.0 kg selamektin
English: Dogs weighing 40.1-60.0 kg.
Maltese: Klieb li jiżnu bejn 40.1 kg u 60.0 kg.
English: Dogs weighing 2.6-5.0 kg.
Maltese: Klieb li jiżnu bejn 2.6 kg u 5.0 kg.
English: Treatment of sarcoptic mange (dogs)
Maltese: Kura għal sarcoptic mange (klieb)
English: Spot-on Use
Maltese: NUMRU TAL-LOTT
English: 12% w/v solution Selamectin 240 mg
Maltese: Chanhold 240 mg għall-klieb soluzzjoni 12% w/v Selamektin 240 mg
English: Cats (kg)
Maltese: INDIKAZZJONI(JIET)
English: 12% w/v solution Selamectin 120 mg
Maltese: Chanhold 120 mg għall-klieb soluzzjoni 12% w/v Selamektin 120 mg
English: 20.1-40.0 1 pipette of Chanhold 240 mg for dogs 20.1-40.0 kg
Maltese: 1-20.0 kg 20,1 - 40,0 1 pipetta ta' Chanhold 240 mg għal klieb 20.
English: • Treatment of biting lice infestations (Trichodectes canis)
Maltese: • Kura għal infestazzjonijiet ta' qamel li jigdem (Trichodectes canis).
English: 12% w/v solution Selamectin 360 mg
Maltese: Chanhold 360 mg għall-klieb soluzzjoni 12% w/v Selamektin 360 mg
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated ) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Maltese: - komuni ħafna (aktar minn wieħed f'10 annimali li juru effett(i) mhux mixtieq(a) matul il-perjodu ta' kura waħda) - komuni (aktar minn wieħed iżda inqas minn 10 annimali f'100 annimal) - mhux komuni (aktar minn wieħed iżda inqas minn10 annimali f'1,000 annimal) - rari (aktar minn wieħed iżda inqas minn10 annimali f'10,000 annimal)
English: Selamectin paralyses and/or kills a wide range of invertebrate parasites through interference with their chloride channel conductance causing disruption of normal neurotransmission.
Maltese: Selamektin tipparalizza u/jew toqtol firxa wiesgħa ta' parassiti invertebrati billi tfixkel il-kunduttività tal-kanali tal-kloru u b'hekk tikkawża tħarbit fin-newrotrasmissjoni normali.
English: Dogs weighing 20.1-40.0 kg.
Maltese: Klieb li jiżnu 20.1 kg-40.
English: 6% w/v solution Selamectin 45 mg
Maltese: Chanhold 45 mg għall-qtates soluzzjoni 6% w/v Selamektin 45 mg
English: • Treatment of adult roundworms (Toxocara cati)
Maltese: • Kura għall-forma adulta tal-ħniex it-tondi (Toxocara cati)
English: Chanhold 15 mg spot-on solution for cats and dogs ≤ 2.5 kg Chanhold 30 mg spot-on solution for dogs 2.6-5.0 kg Chanhold 45 mg spot-on solution for cats 2.6-7.5 kg Chanhold 60 mg spot-on solution for cats 7.6-10.0 kg Chanhold 60 mg spot-on solution for dogs 5.1-10.0 kg Chanhold 120 mg spot-on solution for dogs 10.1-20.0 kg Chanhold 240 mg spot-on solution for dogs 20.1-40.0 kg Chanhold 360 mg spot-on solution for dogs 40.1-60.0 kg selamectin
Maltese: Chanhold 15 mg soluzzjoni għal użu topikali għall-qtates u għall-klieb ≤ 2.5 kg Chanhold 30 mg soluzzjoni għal użu topikali għall-klieb 2.6-5.0 kg Chanhold 45 mg soluzzjoni għal użu topikali għall-qtates 2.6-7.5 kg Chanhold 60 mg soluzzjoni għal użu topikali għall-qtates 7.6-10.0 kg Chanhold 60 mg soluzzjoni għal użu topikali għall-klieb 5.1-10.0 kg Chanhold 120 mg soluzzjoni għal użu topikali għall-klieb 10.
English: Chanhold 15 mg spot-on solution for cats and dogs ≤ 2.5 kg selamectin
Maltese: Chanhold 15 mg soluzzjoni għal użu topikali għall-qtates u għall-klieb ≤ 2.5 kg selamektin
English: The product should be administered topically as a single application of a single-dose delivering a minimum of 6 mg/kg selamectin.
Maltese: Il-prodott għandu jingħata f'applikazzjoni ta' doża waħda li tagħti mill-anqas 6 mg/kg selamektin.
English: Each single-dose (pipette) delivers:
Maltese: Qtates u klieb:
English: • Treatment of adult intestinal roundworms (Toxocara canis).
Maltese: • Kura għall-forma adulta tal-ħniex tondi (Toxocara canis) fl-imsaren.
English: Product mg of selamectin dispensed
Maltese: EFFETTI MHUX MIXTIEQA
English: No undesirable effects were observed after the administration of 10 times the recommended dose.
Maltese: Ma ġewx osservati effetti mhux mixtieqa wara l-għoti ta' 10 darbiet id-doża rakkomandata.
English: The product is available in packs of three pipettes (all strengths), six pipettes (all strengths except 15 mg), or fifteen pipettes (15 mg strength only) in individual foil sachets within an outer carton.
Maltese: Il-prodott huwa disponibbli f'pakketti ta' tliet pipetti (il-qawwiet kollha), sitt pipetti (il-qawwiet kollha ħlief 15 mg), jew ħmistax-il pipetta (saħħa ta' 15 mg biss) fi qratas individwali tal-fojl ġewwa kartuna ta' barra.
English: 12% w/v solution Selamectin 30 mg
Maltese: Chanhold 30 mg għall-klieb soluzzjoni 12% w/v Selamektin 30 mg
English: 6% w/v solution Selamectin 15 mg
Maltese: Chanhold 15 mg għall-klieb u l-qtates soluzzjoni 6% w/v Selamektin 15 mg
English: Spot-on solution.
Maltese: Użu topikali.
English: Cats weighing 2.6-7.5 kg. Cats weighing 7.6-10.0 kg.
Maltese: Qtates li jiżnu bejn 2.6 kg u 7.5 kg.
English: 6% w/v solution Selamectin 60 mg
Maltese: Chanhold 60 mg għall-qtates soluzzjoni 6% w/v Selamektin 60 mg
English: Dogs weighing 10.1-20.0 kg.
Maltese: kg. Klieb li jiżnu bejn 10.1 kg u 20.0
English: 12% w/v solution Selamectin 60 mg
Maltese: Chanhold 60 mg għall-klieb soluzzjoni 12% w/v Selamektin 60 mg
English: This is normal and will disappear typically within 24 hours of treatment administration and does not affect either the safety or efficacy of the veterinary medicinal product.
Maltese: Din hija ħaġa normali u titlaq fi żmien 24 siegħa minn meta jiġi applikat u ma taffettwax innuqqas ta' periklu jew l-effett tal-prodott mediċinali veterinarju.
English: Chanhold 30 mg spot-on solution for dogs 2.6-5.0 kg Chanhold 60 mg spot-on solution for dogs 5.1-10.0 kg Chanhold 120 mg spot-on solution for dogs 10.1-20.0 kg Chanhold 240 mg spot-on solution for dogs 20.1-40.0 kg Chanhold 360 mg spot-on solution for dogs 40.1-60.0 kg selamectin
Maltese: Chanhold 30 mg soluzzjoni għal użu topikali għall-klieb 2.6-5.0 kg Chanhold 60 mg soluzzjoni għal użu topikali għall-klieb 5.1-10.0 kg Chanhold 120 mg soluzzjoni għal użu topikali għall-klieb 10.
English: Cats and dogs weighing 2.5 kg or less (Chanhold 15 mg spot-on solution for cats and dogs ≤ 2.5 kg) Dogs weighing 2.6 kg-5.0 kg (Chanhold 30 mg spot-on solution for dogs 2.6-5.0 kg) Cats weighing 2.6 kg-7.5 kg (Chanhold 45 mg spot-on solution for cats 2.6-7.5 kg) Cats weighing 7.6 kg-10.0 kg (Chanhold 60 mg spot-on solution for cats 7.6-10.0 kg) Dogs weighing 5.1 kg-10.0 kg (Chanhold 60 mg spot-on solution for dogs 5.1-10.0 kg) Dogs weighing 10.1 kg-20.0 kg (Chanhold 120 mg spot-on solution for dogs 10.1-20.0 kg) Dogs weighing 20.1 kg-40.0kg (Chanhold 240 mg spot-on solution for dogs 20.1-40.0 kg) Dogs weighing 40.1 kg-60.0 kg (Chanhold 360 mg spot-on solution for dogs 40.1-60.0 kg)
Maltese: Klieb li jiżnu 2.6 kg-5.0 kg (Chanhold 30 mg soluzzjoni għal użu topikali għall-klieb 2.6-5.0 kg) Qtates li jiżnu 2.6 kg-7.5 kg (Chanhold 45 mg soluzzjoni għal użu topikali għall-qtates 2.6-7.5 kg) Qtates li jiżnu 7.6 kg-10.0
English: The product may be safely administered to animals infected with adult heartworms, however, it is recommended, in accordance with good veterinary practice, that all animals 6 months of age or more living in countries where a vector exists should be tested for existing adult heartworm infections before beginning medication with the product.
Maltese: Il-prodott mediċinali veterinarju ingħata f'doża 3 darbiet aktar minn dik rakkomandata fi qtates u klieb li kellhom heartworms adulti u ma dehrux effetti mhux mixtieqa.
English: Remove the product pipette from its protective package.
Maltese: Neħħi l-pipetta tal-prodott mill-pakkett protettiv.
English: Following absorption from the skin selamectin distributes systemically and is slowly eliminated from plasma as manifested in detectable plasma concentrations in dogs and cats 30 days after administration of a single topical dose at 6 mg/kg.
Maltese: Wara li tiġi assorbita mil-ġilda, selamektin tinfirex fis-sistema u tiġi eliminata mid-demm bil-mod, tant li konċentrazzjonijiet li jistgħu jitkejlu, jinstabu fid-demm tal-klieb u tal-qtates sa 30 ġurnata wara li tkun ingħatat doża topikali ta' 6 mg għal kull kg piż.
English: Selamectin has adulticidal, ovicidal and larvicidal activity against fleas.
Maltese: Dan il-prodott mediċinali veterinarju għandu jiġi applikat biss fuq il-wiċċ tal-ġilda.
English: Chanhold 15 mg spot-on solution for cats and dogs ≤ 2.5 kg Chanhold 30 mg spot-on solution for dogs 2.6-5.0 kg Chanhold 45 mg spot-on solution for cats 2.6-7.5 kg Chanhold 60 mg spot-on solution for cats 7.6-10.0 kg Chanhold 60 mg spot-on solution for dogs 5.1-10.0 kg Chanhold 120 mg spot-on solution for dogs 10.1-20.0 kg Chanhold 240 mg spot-on solution for dogs 20.1-40.0 kg Chanhold 360 mg spot-on solution for dogs 40.1-60.0 kg
Maltese: 1 pipetta ta' Chanhold 15 mg għal qtates u klieb ≤ 2.5 kg 2,6 - 5,0 1 pipetta ta' Chanhold 30 mg għal klieb 2.6-5.0 kg 5,1 - 10,0 1 pipetta ta' Chanhold 60 mg għal klieb 5.1-10.0 kg 10,1 - 20,0 1 pipetta ta' Chanhold 120 mg għal klieb 10.
English: Strength Pharmaceutical Form
Maltese: Pharmaceutical Form
English: The full EPAR for Pioglitazone Teva Pharma can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Maltese: L-EPAR sħiħ għal Pioglitazone Teva Pharma jinstab fis-sit elettroniku tal-Aġenzija: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: Pioglitazone Teva Pharma is a ‘generic medicine'.
Maltese: Pioglitazone Teva Pharma huwa ‘mediċina ġenerika'.